Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	282	173	143	132	97	189
Market Cap Growth	56.77%	21.39%	8.37%	35.38%	-48.72%	169.27%
Enterprise Value	204	140	93	116	54	153
Last Close Price	0.93	0.71	1.25	1.55	1.29	3.02
PS Ratio	366.88	18.13	-	-	-	-
PB Ratio	3.91	1.76	3.48	5.07	2.61	5.37
P/TBV Ratio	3.91	1.76	3.50	6.63	3.16	6.71
EV/Sales Ratio	256.03	14.65	-	-	-	-
Debt / Equity Ratio	-	-	-	0	0.00	0
Net Debt / Equity Ratio	-1.05	-1.02	-1.06	-0.90	-0.97	-0.90
Net Debt / EBITDA Ratio	2.03	6.15	1.52	0.92	1.28	1.95
Net Debt / FCF Ratio	2.43	7.01	1.93	0.87	1.40	2.66
Asset Turnover	0.01	0.13	-	-	-	-
Quick Ratio	13.49	16.13	11.86	5.69	5.67	6.81
Current Ratio	13.86	16.50	12.10	5.81	5.75	6.82
Return on Equity (ROE)	-72.16%	-21.28%	-83.53%	-85.79%	-80.37%	-43.44%
Return on Assets (ROA)	-40.55%	-13.99%	-47.99%	-45.54%	-42.76%	-27.92%
Return on Capital Employed (ROCE)	-51.40%	-16.80%	-70.20%	-98.60%	-76.10%	-46.60%
Earnings Yield	-13.61%	-8.51%	-19.63%	-19.69%	-29.68%	-7.72%
FCF Yield	-	-8.32%	-15.75%	-20.47%	-26.55%	-6.30%
Buyback Yield / Dilution	-104.85%	-41.72%	-33.71%	-3.64%	-28.44%	-26.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.